Topics / Ophthalmology
Weekly issue
Ophthalmology Papers of the Week
The top Ophthalmology papers of the week: the 20 most important new papers of the past week, ranked by potential impact. A new issue comes out every Monday, covering the previous Monday-to-Sunday week.
- 1
- 2Development and Validation of The Glaucoma Risk Stratification Questionnaire for Community Screening
We developed and validated the Glaucoma Risk Stratification Questionnaire (GRSQ), a questionnaire-based instrument for identifying individuals at risk of glaucoma in Chinese communities. Methods This hospital-based cross-sectional study, constituting the instrument development and validation phase of a community screening program, was conducted at West China Hospital, Sichuan University, from December 2025 to August 2026.
- 3TMT-based Quantitative Proteomic Analysis of Vitreous Humor in Proliferative Diabetic Retinopathy
This study used tandem mass tag (TMT) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify DEPs in vitreous samples from PDR patients and MH/EMM control patients.
- 4Effect of Electronic Behavioral Nudges on Low-Value Preoperative Testing
Objective To measure whether electronic health record (EHR)–embedded, behavioral science–informed nudges reduce preoperative testing. Design, Setting, and Participants This pragmatic randomized clinical trial was conducted at a large academic health system (UCLA Health) in Los Angeles, California.
- 5Angiotensin II Type 1 Receptor (AT1R) Drives Human Tenon's Capsule Fibroblast Activation and Myofibroblast Transformation Via The RhoA/ROCK Signaling Pathway
This study investigated the expression of AT1R in human clinical scar specimens, the downstream involvement of the RhoA/ROCK pathway, and the independent anti-fibrotic effects of receptor blockade.
Get papers like these the day they come out, not a week later.
Follow this category- 6Detection of Abnormalities in The RPE in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Chorioretinopathy Using Optical Coherence Tomography-Derived Optical Attenuation Coefficients
To detect abnormalities in the RPE in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) chorioretinopathy, a novel method using optical attenuation coefficients (OACs) was used to enhance the contrast between regions with high and low attenuation.
- 7
- 8Cell-cycle Regulatory Responses in Retinal Degeneration: From Post-mitotic Homeostasis to Cell-state Transitions and Fate Decisions
In this review, we examine cell-cycle perturbations across inherited retinal diseases (IRDs), age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal gliosis and inflammation, and retinal organoid models.
- 9
- 10Gut-hormone Receptor Systems in The Eye: Pharmacological, Local and Putative Endocrine Signalling
This review critically examines gut-hormone-related receptor systems in the eye across three biologically distinct evidence streams: endogenous circulating gut peptides, pharmacological receptor agonism, and locally synthesised ocular peptides.
- 11
- 12Artificial Intelligence for Anti-VEGF Management in Neovascular Age-related Macular Degeneration: from Predictive Models Toward Clinical Decision Agents
However, most published studies remain retrospective, single-center, and prediction-focused, with limited external validation and little direct evidence for clinically deployable closed-loop decision systems. In this narrative review, we synthesize the literature across four linked domains: image interpretation, biomarker quantification, prediction of treatment-related outcomes, and agent-enabling technologies such as home monitoring and language-model-assisted decision support.
- 13Directionally Aligned Nanofibrous Polycaprolactone/gelatin Scaffolds As Durable Scleral Implants for Long‐term Ocular Reconstruction
In this study, we developed electrospun polycaprolactone/gelatin (PCL/GE) nanofibrous scaffolds with controlled fiber orientation for long‐term scleral reconstruction.
- 14
- 15Prognostic Implications of Longitudinal ß-zone Peripapillary Atrophy Enlargement in Myopic Choroidal Neovascularization
To investigate whether longitudinal change of ß-zone peripapillary atrophy (ß-PPA) is associated with long-term outcomes in myopic choroidal neovascularization (mCNV), and to explore its relationship with longitudinal choroidal thickness change. This retrospective longitudinal cohort study included 53 eyes with treatment-naïve subfoveal mCNV that underwent bevacizumab monotherapy and were followed for more than five years.
- 16Activity and Safety of First-line Pumitamig Plus Nab-paclitaxel in Triple-negative Breast Cancer: A Single-arm, Phase 1b/2 Trial
We aimed to evaluate the safety and activity of pumitamig plus nab-paclitaxel as first-line treatment in patients with advanced or metastatic triple-negative breast cancer.
- 17Statin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes
This systematic review and meta-analysis evaluated the association between statin use and the prevalence, incidence, and progression of age-related macular degeneration (AMD).
- 18Genome-Wide Association Study Meta-Analysis of Central Serous Chorioretinopathy
To elucidate the genetic architecture of CSC and map susceptibility loci to specific ocular cell types and molecular pathways. This genetic association study was a genome-wide association study (GWAS) meta-analysis aggregating data from 5 large biobank cohorts and included 2584 patients with CSC and 1 044 455 control participants of European ancestry.
- 19Early Macular Dryness After Four Loading Injections of Faricimab Was Associated with Reduced Two-year Treatment Burden in Treatment-naïve Neovascular Age-related Macular Degeneration
To investigate the association of complete macular dryness after four loading injections of faricimab with treatment burden and dosing intervals over two years in treatment-naïve neovascular age-related macular degeneration (nAMD). This retrospective consecutive case series included treatment-naïve nAMD eyes treated with four monthly loading intravitreal injections of faricimab followed by a treat-and-extend (TAE) regimen in which treatment intervals were adjusted in 2-week increments according to disease activity.
- 20An Update on Pharmacotherapies and Emerging Therapeutic Approaches for Geographic Atrophy
Based on searches of PubMed, trial registries, regulatory documents, and conference proceedings through September 2026, this review examines real-world experience with approved complement inhibitors; next-generation complement approaches, including C1q inhibition, systemic C5 and C3 suppression, and complement-directed gene therapies; and non-complement strategies targeting inflammation, mitochondrial dysfunction, apoptosis, the visual cycle, and iron homeostasis, with photobiomodulation and cell-based therapies as non-pharmacologic comparators.